-
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Rating of "Buy" by Analysts
ソース: Buzz FX / 28 11 2024 03:36:11 America/New_York
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Rating of "Buy" by Analysts Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Shares of ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) have received a
Read more...